AGL: agilon health, inc. Stock

SIC 809 – Miscellaneous Health And Allied Services, Not

Valuation
Market Cap ($M) 1,785.27
Enterprise Value ($M) 1,631.95
Book Value ($M) 470.95
Book Value / Share 1.14
Price / Book 3.79
NCAV ($M) 194.74
NCAV / Share 0.47
Price / NCAV 9.17

Profitability (mra)
Return on Invested Capital (ROIC) -0.51
Return on Assets (ROA) -0.11
Return on Equity (ROE) -0.38

Liquidity (mrq)
Quick Ratio 1.27
Current Ratio 1.27

Balance Sheet (mrq) ($M)
Current Assets 1,457.77
Assets 1,733.98
Liabilities 1,263.03
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 6,060.53
Operating Income -283.96
Net Income -260.15

Cash Flow Statement (mra) ($M)
Cash From Operations -57.78
Cash from Investing 139.89
Cash from Financing -2.58

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
03-07 13G/A Wellington Management Group Llp 6.90 -46.34
02-14 13G Capital International Investors 5.40
12-06 13G/A Fmr Llc 1.80 -74.36
11-13 13G/A Capital World Investors 11.80 -12.41
11-08 13G BlackRock, Inc. 5.80 0.00
11-06 13G/A Morgan Stanley 13.40 26.13

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-02-25 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2024-11-07 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-08-06 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-05-07 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-04-01 722,290 2,667,340 27.08
2025-03-31 524,715 2,631,445 19.94
2025-03-28 531,660 2,982,768 17.82
2025-03-27 552,072 2,716,392 20.32

(click for more detail)

Similar Companies
DVA – DaVita Inc.


Financial data and stock pages provided by
Fintel.io